Product Information
CHLORHEXIDINE 0.12% RINSE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0073 per ML under NDC 16571012848. Its NADAC has been published 147 times since Dec 13, 2023.
FDA first approved this application on Nov 14, 2000. Its Orange Book therapeutic-equivalence code is AT.
Strength
1.2 mg/mL
Manufacturer
Rising Pharma Holdings Inc.NDC
16571012848
Classification
Generic
Dosage Form
SOLUTION
Route
DENTAL
Effective Date
9/23/2026
Active Ingredients
CHLORHEXIDINE GLUCONATEApproval Type
Generic (ANDA)
FDA Application
ANDA075561FDA Approved
11/14/2000
TE Code
AT
On Market Since
7/27/2023
Pharmacological Classes
Price Statistics
The NADAC for CHLORHEXIDINE 0.12% RINSE has been published 147 times since Dec 13, 2023, and over the history we have for it it has risen 40.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0073 per ML |
|---|---|
| All-time high | $0.0077 (Nov 13, 2024) |
| All-time low | $0.0044 (Jan 17, 2024) |
| 52-week high | $0.0075 |
| 52-week low | $0.0071 |
| Median price | $0.0073 |
| Average price | $0.0070 |
| Largest weekly change | +59.4% (Mar 20, 2024) |
| Weeks tracked | 147 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Chlorhexidine Gluconate Oral Rinse market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Chlorhexidine Gluconate Oral Rinse market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLORHEXIDINE 0.12% RINSE?
The current National Average Drug Acquisition Cost (NADAC) for CHLORHEXIDINE 0.12% RINSE, manufactured by Rising Pharma Holdings Inc., is $0.0073 per ML (NDC 16571012848), effective Sep 30, 2026.
How has the price of CHLORHEXIDINE 0.12% RINSE changed over time?
Over the history we have for it, the NADAC for CHLORHEXIDINE 0.12% RINSE has risen 40.9%. It has been tracked across 147 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for CHLORHEXIDINE 0.12% RINSE?
Since Dec 13, 2023, the NADAC for CHLORHEXIDINE 0.12% RINSE has ranged from a low of $0.0044 (Jan 17, 2024) to a high of $0.0077 (Nov 13, 2024), with a median of $0.0073 per ML.
Are there cheaper alternatives to CHLORHEXIDINE 0.12% RINSE?
No other NADAC-published product currently shares the active ingredient and strength of CHLORHEXIDINE 0.12% RINSE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHLORHEXIDINE 0.12% RINSE?
CHLORHEXIDINE 0.12% RINSE (NDC 16571012848) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.